Nasdaq
NTLA
Intellia Therapeutics, Inc.
- Health Care
- Listed 2016
- 1 day
- +2.5%
- 1 month
- −35.5%
- 1 year
- −1.1%
$11.24 · Mkt cap $1.57B
At the 6 Aug 2026 close
Nasdaq
Intellia Therapeutics, Inc.
$11.24 · Mkt cap $1.57B
At the 6 Aug 2026 close
Intellia Therapeutics, Inc. trades under the ticker NTLA on Nasdaq, in the Health Care sector (Biotechnology: In Vitro & In Vivo Diagnostic Substances). It has been listed since 2016. Its market capitalisation is $1.57B. The last closing price was $11.24, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is −1.1%, and −35.5% over the past month. Returns are price returns and exclude dividends.
This page exists because NTLA is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.